Cost-effectiveness and carbon footprint of cystoscopic surveillance schedules in non-muscle-invasive bladder cancer

Bladder cancer is a common illness, and for many patients, the most dangerous phase is not the initial tumor but the years of watching and waiting that follow. When the cancer has not grown into the deep muscle of the bladder wall, doctors call it non-muscle-invasive bladder cancer. Because this type of cancer tends to return rather than spread immediately, patients are treated like people with a chronic condition. They must undergo a procedure called a cystoscopy, where a thin, flexible tube with a camera is inserted to look inside the bladder, repeatedly over many years. This surveillance is designed to catch any new growths early, but it creates a heavy burden of medical visits, costs, and environmental waste. While doctors and hospitals have long debated whether to use reusable instruments or disposable ones to reduce waste, a new study asks a broader question: does the sheer number of these check-ups matter more for the planet than the type of tool used?

Researchers at Shandong Zaozhuang Municipal Hospital in China built a detailed computer simulation to track the lives of bladder cancer patients over fifteen years. They did not just look at the money spent or the carbon dioxide emitted by a single hospital visit; they modeled the entire chain of events triggered by a surveillance schedule. In their model, they compared the standard medical guidelines, which suggest different check-up frequencies based on how risky a patient's cancer is, against several other approaches. These included checking everyone more often, checking everyone less often, and using a mix of strategies. They calculated the cost in United States dollars, the quality of life for the patients, and the total carbon footprint in kilograms of carbon dioxide equivalent, a standard way to measure greenhouse gas emissions.

The study revealed a surprising truth about where the environmental damage comes from. Most people assume that the carbon footprint of a medical procedure is dominated by the equipment used, such as the plastic casing of a disposable scope versus the energy needed to clean a reusable one. However, the researchers found that the cystoscopy itself is a minor player in the environmental story. Whether the doctor used a reusable scope or a single-use one, the emissions from the exam itself were small, ranging from 6 to 26 kilograms of carbon dioxide per patient over fifteen years. The vast majority of the pollution, between 269 and 487 kilograms per patient, came from what happened after the exam. When a cystoscopy finds a new tumor, the patient must undergo a surgical removal of that tumor and often a course of treatment where medicine is placed directly into the bladder. These follow-up treatments are the true heavyweights of the carbon footprint, accounting for more than 94 percent of the total emissions.

This means that the frequency of the check-ups is far more important than the choice of the instrument. The more often a patient is checked, the more likely a recurrence is to be found, and the more often the patient must undergo the heavy-emission surgeries and treatments. The researchers tested a strategy where they checked patients much more frequently than the guidelines recommend, using a strict three-month schedule for everyone. This approach increased the total cost by 130 percent and the carbon emissions by 86 percent, yet it did not save any lives or prevent the cancer from becoming more dangerous. The extra checks simply found problems earlier, which led to more surgeries, but the final outcome for the patient remained the same. The earlier detection did not translate into better survival rates because the cancer in these patients grows slowly enough that waiting a few extra months to find it does not change the result.

The study also looked at whether doctors could safely check patients less often, particularly those with low-risk cancer. In the simulation, reducing the surveillance for low-risk patients to just a single check-up three months after their initial surgery, followed by no further scheduled exams, cut the cost by 69 percent and the carbon emissions by 96 percent. Crucially, this drastic reduction did not increase the risk of the cancer spreading or the patient dying from it. The model showed that for low-risk patients, the standard frequent check-ups were generating unnecessary procedures and emissions without providing a safety benefit. The researchers found that the standard guidelines, which already vary the check-up frequency based on risk, were actually the most efficient balance of cost, safety, and environmental impact. Uniformly increasing the frequency for everyone was wasteful, while carefully reducing it for the lowest-risk group was highly beneficial.

The findings suggest that the path to a more sustainable medical system lies not in swapping out plastic for metal, but in being more precise about who needs to be watched and how often. The carbon footprint of bladder cancer care is driven by the volume of surgeries and treatments that follow a detection, not by the camera used to find the tumor. By sticking to risk-based guidelines and avoiding the temptation to check everyone more frequently, hospitals can significantly lower their environmental impact and costs without compromising patient safety. The study concludes that for low-risk patients, a single early check-up followed by a return to normal life if no problems are found is a strategy that saves money, saves the planet, and keeps patients just as safe as the current standard of care.